AstraZeneca PLC (AZN)
166.80
+0.82
(+0.49%)
USD |
NYSE |
Aug 24, 16:00
166.71
-0.09
(-0.05%)
After-Hours: 20:00
AstraZeneca Price to Book Value : 10.93 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 10.88 |
| August 20, 2026 | 10.78 |
| August 19, 2026 | 10.81 |
| August 18, 2026 | 10.49 |
| August 17, 2026 | 10.28 |
| August 14, 2026 | 10.25 |
| August 13, 2026 | 10.30 |
| August 12, 2026 | 10.39 |
| August 11, 2026 | 10.40 |
| August 10, 2026 | 10.61 |
| August 07, 2026 | 10.58 |
| August 06, 2026 | 10.55 |
| August 05, 2026 | 10.58 |
| August 04, 2026 | 10.20 |
| August 03, 2026 | 10.35 |
| July 31, 2026 | 11.12 |
| July 30, 2026 | 11.23 |
| July 29, 2026 | 11.36 |
| July 28, 2026 | 11.30 |
| July 27, 2026 | 11.12 |
| July 24, 2026 | 11.09 |
| July 23, 2026 | 11.03 |
| July 22, 2026 | 11.12 |
| July 21, 2026 | 11.10 |
| July 20, 2026 | 10.78 |
| Date | Value |
|---|---|
| July 17, 2026 | 11.07 |
| July 16, 2026 | 11.09 |
| July 15, 2026 | 11.03 |
| July 14, 2026 | 10.78 |
| July 13, 2026 | 11.11 |
| July 10, 2026 | 11.25 |
| July 09, 2026 | 11.70 |
| July 08, 2026 | 12.40 |
| July 07, 2026 | 12.65 |
| July 06, 2026 | 12.46 |
| July 02, 2026 | 12.79 |
| July 01, 2026 | 12.05 |
| June 30, 2026 | 12.43 |
| June 29, 2026 | 12.51 |
| June 26, 2026 | 12.35 |
| June 25, 2026 | 12.17 |
| June 24, 2026 | 11.99 |
| June 23, 2026 | 11.86 |
| June 22, 2026 | 11.56 |
| June 18, 2026 | 11.46 |
| June 17, 2026 | 11.66 |
| June 16, 2026 | 11.71 |
| June 15, 2026 | 11.62 |
| June 12, 2026 | 11.71 |
| June 11, 2026 | 11.94 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| GSK Plc | 4.473 |
| Johnson & Johnson | 7.739 |
| Eli Lilly & Co. | 34.67 |
| Merck & Co., Inc. | 8.873 |
| Novo Nordisk A/S | 6.132 |
Price to Book Value Related Metrics
| PE Ratio | 50.09 |
| PS Ratio | 8.611 |
| PEG Ratio | 1.473 |
| Price to Free Cash Flow | 64.68 |
| Price | 166.80 |
| Earnings Yield | 2.00% |
| Market Cap | 517.36B |
| PEGY Ratio | 1.393 |
| Operating PE Ratio | 37.07 |
| Normalized PE Ratio | 49.51 |